JHS Svendgaard Laboratories Limited (JHS.NS)
INR 22.38
(0.41%)
INR 22.38
(0.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 183.68 Million INR | -60.84% |
| 2022 | 469.05 Million INR | 56.44% |
| 2021 | 299.83 Million INR | 7.15% |
| 2020 | 279.82 Million INR | -32.7% |
| 2019 | 415.81 Million INR | 10.64% |
| 2018 | 375.83 Million INR | -6.44% |
| 2017 | 401.68 Million INR | 22.27% |
| 2016 | 328.52 Million INR | 9.37% |
| 2015 | 300.37 Million INR | -1.15% |
| 2014 | 303.87 Million INR | -8.45% |
| 2013 | 331.92 Million INR | -8.87% |
| 2012 | 364.21 Million INR | 49.57% |
| 2011 | 243.51 Million INR | 28.88% |
| 2010 | 188.95 Million INR | 19.59% |
| 2009 | 157.99 Million INR | 57.59% |
| 2008 | 100.25 Million INR | 52.35% |
| 2007 | 65.8 Million INR | 99.11% |
| 2006 | 33.05 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 56.61 Million INR | 53.36% |
| 2023 Q1 | 110.35 Million INR | -17.12% |
| 2023 FY | 183.68 Million INR | -60.84% |
| 2023 Q3 | 42.41 Million INR | -54.44% |
| 2023 Q4 | 36.91 Million INR | -12.96% |
| 2023 Q2 | 93.08 Million INR | -15.65% |
| 2022 Q3 | 117.6 Million INR | -4.86% |
| 2022 Q2 | 123.61 Million INR | 37.29% |
| 2022 Q1 | 90.03 Million INR | 97.64% |
| 2022 FY | 469.05 Million INR | 56.44% |
| 2022 Q4 | 133.15 Million INR | 13.21% |
| 2021 Q3 | 86.44 Million INR | -2.17% |
| 2021 Q1 | 79.48 Million INR | 261.26% |
| 2021 Q4 | 45.55 Million INR | -47.3% |
| 2021 FY | 299.83 Million INR | 7.15% |
| 2021 Q2 | 88.35 Million INR | 11.16% |
| 2020 Q3 | 98.15 Million INR | -2.1% |
| 2020 FY | 279.82 Million INR | -32.7% |
| 2020 Q2 | 100.26 Million INR | 68.76% |
| 2020 Q1 | 59.41 Million INR | -22.8% |
| 2020 Q4 | 22 Million INR | -77.58% |
| 2019 Q2 | 119.69 Million INR | 15.25% |
| 2019 Q1 | 103.85 Million INR | 73.1% |
| 2019 Q4 | 76.95 Million INR | -33.27% |
| 2019 Q3 | 115.31 Million INR | -3.66% |
| 2019 FY | 415.81 Million INR | 10.64% |
| 2018 Q2 | 109.2 Million INR | 12.33% |
| 2018 FY | 375.83 Million INR | -6.44% |
| 2018 Q4 | 59.99 Million INR | -45.16% |
| 2018 Q3 | 109.4 Million INR | 0.18% |
| 2018 Q1 | 97.22 Million INR | -20.23% |
| 2017 Q4 | 121.87 Million INR | -1.4% |
| 2017 FY | 401.68 Million INR | 22.27% |
| 2017 Q3 | 123.6 Million INR | 56.48% |
| 2017 Q2 | 78.98 Million INR | -1.68% |
| 2017 Q1 | 80.34 Million INR | -8.94% |
| 2016 Q2 | 79.68 Million INR | 24.49% |
| 2016 FY | 328.52 Million INR | 9.37% |
| 2016 Q1 | 64.01 Million INR | -22.22% |
| 2016 Q4 | 88.22 Million INR | 9.07% |
| 2016 Q3 | 80.88 Million INR | 1.51% |
| 2015 Q2 | 74.87 Million INR | 13.23% |
| 2015 Q4 | 82.29 Million INR | 4.25% |
| 2015 Q3 | 78.94 Million INR | 5.43% |
| 2015 FY | 300.37 Million INR | -1.15% |
| 2015 Q1 | 66.12 Million INR | -16.01% |
| 2014 Q4 | 78.73 Million INR | 11.91% |
| 2014 FY | 303.87 Million INR | -8.45% |
| 2014 Q1 | 77.6 Million INR | 65.95% |
| 2014 Q3 | 70.35 Million INR | -7.55% |
| 2014 Q2 | 76.09 Million INR | -1.94% |
| 2013 Q1 | 93.81 Million INR | -46.36% |
| 2013 Q3 | 70.71 Million INR | -21.1% |
| 2013 FY | 331.92 Million INR | -8.87% |
| 2013 Q2 | 89.63 Million INR | -4.46% |
| 2013 Q4 | 46.76 Million INR | -33.87% |
| 2012 Q4 | 174.89 Million INR | 128.83% |
| 2012 FY | 364.21 Million INR | 49.57% |
| 2012 Q2 | 64.27 Million INR | 32.21% |
| 2012 Q1 | 48.61 Million INR | 0.0% |
| 2012 Q3 | 76.43 Million INR | 18.92% |
| 2011 FY | 243.51 Million INR | 28.88% |
| 2010 FY | 188.95 Million INR | 19.59% |
| 2009 FY | 157.99 Million INR | 57.59% |
| 2008 FY | 100.25 Million INR | 52.35% |
| 2007 FY | 65.8 Million INR | 99.11% |
| 2006 FY | 33.05 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 196.31 Million INR | 6.434% |
| Bajaj Consumer Care Limited | 3.9 Billion INR | 95.295% |
| BCL Industries Limited | 407.57 Million INR | 54.933% |
| Colgate-Palmolive (India) Limited | 36.87 Billion INR | 99.502% |
| Cupid Limited | 176 Million INR | -4.366% |
| Dabur India Limited | 21.91 Billion INR | 99.162% |
| Emami Limited | 10.72 Billion INR | 98.287% |
| Gillette India Limited | 5.5 Billion INR | 96.662% |
| Godrej Consumer Products Limited | 34.56 Billion INR | 99.469% |
| Hindustan Unilever Limited | 96.12 Billion INR | 99.809% |
| Honasa Consumer Limited | 8.36 Billion INR | 97.805% |
| Jyothy Labs Limited | 5.72 Billion INR | 96.793% |
| Kaya Limited | 1.3 Billion INR | 85.887% |
| Marico Limited | 21.36 Billion INR | 99.14% |
| N.K Industries Limited | 201.82 Million INR | 8.99% |
| Procter & Gamble Hygiene and Health Care Limited | 8.13 Billion INR | 97.742% |
| S H Kelkar and Company Limited | 2.69 Billion INR | 93.174% |